4WA9 | The crystal structure of human abl1 wild type kinase domain in complex with axitinib | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Johnson, E., McTigue, M., Cronin, C.N. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 | ||||||||||||
ligand | AXI | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation., Pemovska T, Johnson E, Kontro M, Repasky GA, Chen J, Wells P, Cronin CN, McTigue M, Kallioniemi O, Porkka K, Murray BW, Wennerberg K, Nature. 2015 Feb 9. doi: 10.1038/nature14119. PMID:25686603 |
Data retrieval |
View 4WA9 in 3D |
Visual 3D analysis of 4WA9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4WA9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |